COVID-19 has vividly demonstrated the risk of a catastrophic biological event. This is magnified by an increasingly interconnected world, challenged by political instability, urbanization, climate change, and new technologies that make it easier, cheaper, and faster to create and engineer pathogens.
NTI joined governments and organizations from around the world for the 2nd Global COVID-19 Summit on May 12, 2022 and committed to provide $35,000 to the pandemic preparedness and global health security financial intermediary fund.
An assessment and benchmarking of health security and related capabilities across 195 countries.
Preventing global catastrophic biological risks (GCBRS)
Advances in biotechnology outpace national governments’ ability to provide needed oversight to prevent accidents or deliberate misuse of dangerous biological agents.
Reducing the risks of biological misuse and enhancing global security
Past Project Safeguarding modern bioscience and biotechnology so it can advance and flourish safely and responsibly
Past Project Rapidly assessing origins of high-consequence global biological events
NTI | bio experts will take part in several GHS2026 sessions, including a preview of findings from the forthcoming Africa Health Security (AHS) Index and a timely discussion on strengthening health security partnerships amid declining resources.
Amid a combination of economic slowdown, reductions in official development assistance, rising biological threats, and climate change’s disproportionate impact on Africa, leaders and experts call for data-driven tools to guide strategic health security investments.
A statement by Jaime M. Yassif, PhD, vice president, NTI Global Biological Policy and Programs.
NTI applauds today’s announcement that the International Negotiating Body of the World Health Organization (WHO) has reached a deal on the language of the Pandemic Accord. Pandemics continue to pose a global threat, and this proposed agreement is proof that the world can unify to reduce the most catastrophic risks.
Dr. Jennifer Nuzzo, DrPH, a professor of epidemiology and director of the Pandemic Center at the Brown University School of Public Health, is one of 100 new members to join the National Academy of Medicine (NAM) as part of its 2024 class.
Sign up for regular updates on innovative, real-world solutions to existential threats.
